Parametric Portfolio Associates’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,107
Closed -$136K 3597
2021
Q1
$136K Sell
1,107
-59
-5% -$8.55K ﹤0.01% 3940
2020
Q4
$133K Sell
1,166
-233
-17% -$29.3K ﹤0.01% 3856
2020
Q3
$167K Buy
1,399
+547
+64% +$63.8K ﹤0.01% 3711
2020
Q2
$106K Sell
852
-227
-21% -$30.7K ﹤0.01% 3776
2020
Q1
$208K Buy
1,079
+632
+141% +$198K ﹤0.01% 3538
2019
Q4
$149K Buy
447
+32
+8% +$10.7K ﹤0.01% 3800
2019
Q3
$134K Sell
415
-515
-55% -$166K ﹤0.01% 3782
2019
Q2
$401K Buy
930
+395
+74% +$195K ﹤0.01% 3463
2019
Q1
$303K Buy
535
+309
+137% +$148K ﹤0.01% 3545
2018
Q4
$67K Buy
+226
New +$101K ﹤0.01% 3824

Other funds holding VYNE